• Mashup Score: 0

    Bulevirtide improved quality of life measures among patients treated for chronic hepatitis D virus, Maria Buti, MD, PhD, of the Hospital Universiario Valle Hebron, told Healio Gastroenterology. In a multicenter, randomized, phase 3 study, researchers evaluated the health-related quality of life benefits as measured by the Hepatitis Quality of Life Questionnaire (HQLQ) following 24 weeks of

    Tweet Tweets with this article
    • VIDEO: #Bulevirtide improves quality of life in chronic #HDV #NASPGHAN21 @NASPGHAN https://t.co/jugvKFOqWp

  • Mashup Score: 0

    Hepatitis D, in hepatitis B surface antigen-positive individuals, may remain undiagnosed due to lack of testing, particularly in primary care settings, according to a poster. Worldwide, chronic hepatitis D infection often goes unrecognized, partly because it is considered an orphan disease that professionals do not pay much attention to, Adriana Palom, of the Hospital Universitari Vall

    Tweet Tweets with this article
    • #ICYMI: Large proportion of undiagnosed anti #HDV positive individuals due to lack of testing #LiverMtg21 @AASLDtweets @AASLDFoundation https://t.co/o04zb1RHGh

  • Mashup Score: 3

    Assessing hepatitis D virus patients for viremia, as well as expanded screening for HDV antibodies in hepatitis B virus patients, may help further identify active HDV cases, according to a presentation at UEG Week Virtual. “Our study nicely showed that the number of confirmed HDV cases in Austria is low, but potentially underestimated due to a lack of testing for anti-HDV antibodies in HBV

    Tweet Tweets with this article
    • Assessing #hepatitisD virus patients for viremia, as well as expanded screening for #HDV antibodies in #hepatitisB virus patients, may help further identify active HDV cases #UEGWeek #GITwitter #MedTwitter https://t.co/7cPi9mWOPM

  • Mashup Score: 4

    Approximately 5% of individuals infected with hepatitis B virus (HBV) are coinfected with hepatitis D virus (HDV). Chronic HBV/HDV coinfection is associated with an unfavourable outcome, with many patients developing liver cirrhosis, liver failure and eventually hepatocellular carcinoma within 5–10 years. The identification of the HBV/HDV receptor and the development of novel in vitro and animal…

    Tweet Tweets with this article
    • #GUTImage showing the #HDV life cycle, spreading pathways and drug targets from the paper "Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease" via https://t.co/Af7h9mqTfw #HDV #HepatitisD #livertwitter #viralhepatitis https://t.co/togXWtfHer